For Additional Information

FDA - Generic Drugs: What You Need to Know – 2002 Q&A about generic drugs – states that they’re safe to use because the FDA requires generics to be safe and effective, and that “people can use them with total confidence.”

FDA/Center for Drug Evaluation and Research – FDA Ensures Equivalence of Generic Drugs – 2003 This article explains steps taken to review a drug, the FDA’s requirements for brand name and generic drugs, myths and facts about generic drugs, and bioequivalence.

FDA - FDA Generic Drugs Final Rule and Initiative – 2003 Features links to the FDA’s fact sheet, white paper, and Q&A on their Final Rule about the regulations of generic drugs. This article also emphasizes the importance of saving money with generic drugs by streamlining and perfecting the process of generic drug review and production.

AAN Policy Statement The American Academy of Neurology (AAN), representing over 19,000 neurologists and neuroscience professionals, has taken an active interest in the clinical, ethical and policy considerations concerning the coverage of anticonvulsant drugs for people with epilepsy.

National Black Caucus of State Legislators Position statement from the National Black Caucas of State Legislators. (PDF)


» The Issue » Our Position » Take Our Survey » Report Problems to FDA » How Medicines Work » Glossary of Terms » Other Resources	For Additional Information FDA - Generic Drugs: What You Need to Know – 2002 Q&A about generic drugs – states that they’re safe to use because the FDA requires generics to be safe and effective, and that “people can use them with total confidence.” FDA/Center for Drug Evaluation and Research – FDA Ensures Equivalence of Generic Drugs – 2003 This article explains steps taken to review a drug, the FDA’s requirements for brand name and generic drugs, myths and facts about generic drugs, and bioequivalence. FDA - FDA Generic Drugs Final Rule and Initiative – 2003 Features links to the FDA’s fact sheet, white paper, and Q&A on their Final Rule about the regulations of generic drugs. This article also emphasizes the importance of saving money with generic drugs by streamlining and perfecting the process of generic drug review and production. AAN Policy Statement The American Academy of Neurology (AAN), representing over 19,000 neurologists and neuroscience professionals, has taken an active interest in the clinical, ethical and policy considerations concerning the coverage of anticonvulsant drugs for people with epilepsy. National Black Caucus of State Legislators Position statement from the National Black Caucas of State Legislators. (PDF)


Epilepsy Foundation 8301 Professional Place Landover, MD 20785-7223 - (800) 332-1000 Contact Us Site Copyright © 2006. Disclaimer of warranties and liability. Questions or comments about the website?